FDA slammed for perpetuating “confusion and gray area” in CBD supplement regulation

The US food and drug agency holds its ground that risks run too high to allow the ingredient to be openly marketed

Related Articles

Amanita muscaria mushroom (red with white dots) in the forest.

NUTRITION & HEALTH NEWS

12 Jun 2024 --- US-based researchers warn that the unregulated sales of Amanita muscaria, an increasingly popular “magic mushroom,” endanger public health.... Read More

Lion's Mane mushroom growing on a tree.

NUTRITION & HEALTH NEWS

10 Jun 2024 --- As mushrooms gather consumer and market interest, product applications ranging from mental health supplements to coffee alternatives take the spotlight.... Read More

Protein powder, shake and bar next to a notepad that says "be fit"

NUTRITION & HEALTH NEWS

05 Jun 2024 --- A new study reveals a high use of muscle-building supplements, such as protein bars and powder, among Canadian adolescents and young adults (aged 16 to... Read More

Researcher in a lab coat looking through a microscope behind plants in glass viles.

NUTRITION & HEALTH NEWS

30 May 2024 --- As consumer demand for effective, natural products continues to grow, Pharmactive Biotech Products highlights the importance of clinical research and... Read More

MegaFood Omega 3-6-9

NUTRITION & HEALTH NEWS

30 May 2024 --- US-based vitamin and minerals producer MegaFood has launched Omega 3-6-9, a plant-based complex with a combination of fatty acids from botanicals... Read More

trans